V. Institut-de and . Sanitaire, Weekly Epidemiological Bulletin influenza A (H1N1) 2009. Situation UpdateBulletin hebdomadaire grippe, 2010.

V. Institut-de and . Sanitaire, Estimations of the number of infections of influenza A (H1N1) 2009 in mainland France 17, 2009.

A. Bone, J. Guthmann, J. Nicolau, and D. Levy-bruhl, Population and risk group uptake of H1N1 influenza vaccine in mainland France 2009???2010: Results of a national vaccination campaign, Vaccine, vol.28, issue.51, pp.8157-8161, 2010.
DOI : 10.1016/j.vaccine.2010.09.096

E. Miller, K. Hoschler, P. Hardelid, E. Stanford, and N. Andrews, Incidence of 2009 pandemic influenza A H1N1 infection in England: a cross-sectional serological study, The Lancet, vol.375, issue.9720, pp.1100-1108, 2010.
DOI : 10.1016/S0140-6736(09)62126-7

M. Chen, V. Lee, W. Lim, I. Barr, and R. Lin, 2009 Influenza A(H1N1) Seroconversion Rates and Risk Factors Among Distinct Adult Cohorts in Singapore, JAMA, vol.303, issue.14, pp.1383-1391, 2009.
DOI : 10.1001/jama.2010.404

S. Riley, K. Kwok, K. Wu, D. Ning, and B. Cowling, Epidemiological Characteristics of 2009 (H1N1) Pandemic Influenza Based on Paired Sera from a Longitudinal Community Cohort Study, PLoS Medicine, vol.361, issue.6, p.1000442, 2011.
DOI : 10.1371/journal.pmed.1000442.s009

J. Wu, E. Ma, C. Lee, D. Chu, and P. Ho, The Infection Attack Rate and Severity of 2009 Pandemic H1N1 Influenza in Hong Kong, Clinical Infectious Diseases, vol.51, issue.10, pp.1184-1191, 2010.
DOI : 10.1086/656740

M. Zambon, Laboratory Diagnosis of Influenza, Textbook of Influenza. Oxford, United Kingdom: Blackwell. pp, pp.291-313, 1998.

D. Palmer, W. Dowdle, M. Coleman, and G. Schild, Procedural guide, Part 2: Haemmagglutination-inhibition test In: Advanced laboratory technicals for immunological diagnostic, Atlanta Immunology Ser, pp.25-62, 1975.

J. De-jong, A. Palache, W. Beyer, G. Rimmelzwaan, and A. Boon, Haemagglutination-inhibiting antibody to influenza virus, Dev Biol, vol.115, pp.63-73, 2003.

A. Barros and V. Hirakata, Alternatives for logistic regression in cross-sectional studies: an empirical comparison of models that directly estimate the prevalence ratio, BMC Medical Research Methodology, vol.37, issue.1, p.21, 2003.
DOI : 10.1590/S0034-89102003000300017

A. Perruccio, J. Power, and E. Badley, The relative impact of 13 chronic conditions across three different outcomes, Journal of Epidemiology & Community Health, vol.61, issue.12, pp.1056-1061, 2007.
DOI : 10.1136/jech.2006.047308

. Stata-statistical-software, College Station, TX: StataCorp LP, 2009.

D. Bandaranayake, Q. Huang, A. Bissielo, T. Wood, and G. Mackereth, Risk Factors and Immunity in a Nationally Representative Population following the 2009 Influenza A(H1N1) Pandemic, PLoS ONE, vol.7, issue.10, p.13211, 2010.
DOI : 10.1371/journal.pone.0013211.s001

G. Gilbert, M. Cretikos, L. Hueston, G. Doukas, O. Toole et al., Influenza A (H1N1) 2009 Antibodies in Residents of New South Wales, Australia, after the First Pandemic Wave in the 2009 Southern Hemisphere Winter, PLoS ONE, vol.375, issue.9, p.12562, 2010.
DOI : 10.1371/journal.pone.0012562.t004

N. Mcleish, P. Simmonds, C. Robertson, I. Handel, and M. Mcgilchrist, Sero-Prevalence and Incidence of A/H1N1, PLoS One, vol.6, issue.6, 2009.

J. Delangue, N. Salez, L. Ninove, A. Kieffer, and C. Zandotti, Serological study of the 2009 pandemic due to influenza A H1N1 in the metropolitan French population, Clinical Microbiology and Infection, vol.18, issue.2, 2011.
DOI : 10.1111/j.1469-0691.2011.03545.x

S. Dudareva, B. Schweiger, M. Thamm, M. Hohle, and K. Stark, Prevalence of Antibodies to 2009 Pandemic Influenza A (H1N1) Virus in German Adult Population in Pre- and Post-Pandemic Period, PLoS ONE, vol.172, issue.6, p.21340, 2011.
DOI : 10.1371/journal.pone.0021340.s005

M. Baguelin, K. Hoschler, E. Stanford, P. Waight, and P. Hardelid, Age-Specific Incidence of A/H1N1 2009 Influenza Infection in England from Sequential Antibody Prevalence Data Using Likelihood-Based Estimation, PLoS ONE, vol.361, issue.10, p.17074, 2011.
DOI : 10.1371/journal.pone.0017074.t001

F. Carrat, E. Vergu, N. Ferguson, M. Lemaitre, and S. Cauchemez, Time Lines of Infection and Disease in Human Influenza: A Review of Volunteer Challenge Studies, American Journal of Epidemiology, vol.167, issue.7, pp.775-785, 2008.
DOI : 10.1093/aje/kwm375

B. Tandale, S. Pawar, Y. Gurav, M. Chadha, and S. Koratkar, Seroepidemiology of pandemic influenza A (H1N1) 2009 virus infections in Pune, India, BMC Infectious Diseases, vol.49, issue.5, p.255, 2010.
DOI : 10.1086/644775

A. Flahault, X. De-lamballerie, C. Pellat, N. Salez, and T. Hanslik, Symptomatic infections less frequent with H1N1pdm than with seasonal strains, PLoS Currents, vol.1, 2009.
DOI : 10.1371/currents.RRN1140

URL : http://doi.org/10.1371/currents.rrn1140

Y. Chan, C. Lee, S. Hwang, C. Fung, and F. Wang, Seroprevalence of Antibodies to Pandemic (H1N1) 2009 Influenza Virus Among Hospital Staff in a Medical Center in Taiwan, Journal of the Chinese Medical Association, vol.73, issue.2, pp.62-66, 2010.
DOI : 10.1016/S1726-4901(10)70003-4

C. Rizzo, M. Rota, A. Bella, V. Alfonsi, and S. Declich, Cross-reactive antibody responses to the 2009 A/H1N1v influenza virus in the Italian population in the pre-pandemic period, Vaccine, vol.28, issue.20, pp.3558-3562, 2010.
DOI : 10.1016/j.vaccine.2010.03.006

D. Skowronski, T. Hottes, J. Mcelhaney, N. Janjua, and S. Sabaiduc, Immuno-epidemiologic Correlates of Pandemic H1N1 Surveillance Observations: Higher Antibody and Lower Cell-Mediated Immune Responses with Advanced Age, Journal of Infectious Diseases, vol.203, issue.2, pp.158-167, 2011.
DOI : 10.1093/infdis/jiq039

S. Zimmer, C. Crevar, D. Carter, J. Stark, and B. Giles, Seroprevalence Following the Second Wave of Pandemic 2009 H1N1 Influenza in Pittsburgh, PA, USA, PLoS ONE, vol.324, issue.7, p.11601, 2010.
DOI : 10.1371/journal.pone.0011601.t002

H. Chen, Y. Wang, W. Liu, J. Zhang, and B. Dong, Serologic Survey of Pandemic (H1N1) 2009 Virus, Guangxi Province, China, Emerging Infectious Diseases, vol.15, issue.11, pp.1849-1850, 2009.
DOI : 10.3201/eid1511.090868

N. Ikonen, M. Strengell, L. Kinnunen, P. Osterlund, and J. Pirhonen, High frequency of cross-reacting antibodies against 2009 pandemic influenza A(H1N1) virus among the elderly in Finland, Euro Surveill, vol.15, 2010.

K. Hancock, V. Veguilla, X. Lu, W. Zhong, and E. Butler, Cross-Reactive Antibody Responses to the 2009 Pandemic H1N1 Influenza Virus, New England Journal of Medicine, vol.361, issue.20, pp.1945-1952, 2009.
DOI : 10.1056/NEJMoa0906453

S. Epstein, Prior H1N1 Influenza Infection and Susceptibility of Cleveland Family Study Participants during the H2N2 Pandemic of 1957: An Experiment of Nature, The Journal of Infectious Diseases, vol.193, issue.1, pp.49-53, 2006.
DOI : 10.1086/498980

D. Skowronski, T. Hottes, N. Janjua, D. Purych, and S. Sabaiduc, Prevalence of seroprotection against the pandemic (H1N1) virus after the 2009 pandemic, Canadian Medical Association Journal, vol.182, issue.17, pp.1851-1856, 2010.
DOI : 10.1503/cmaj.100910

K. Waalen, A. Kilander, S. Dudman, G. Krogh, and T. Aune, High prevalence of antibodies to the 2009 pandemic influenza A(H1N1) virus in the Norwegian population, Euro Surveill, vol.15, 2009.

P. Hardelid, D. Fleming, J. Mcmenamin, N. Andrews, and C. Robertson, Effectiveness of pandemic and seasonal influenza vaccine in preventing pandemic influenza A(H1N1)2009 infection in England and Scotland, Euro Surveill, vol.16, 2009.

W. Kunzel, H. Glathe, H. Engelmann, and H. Van, Kinetics of humoral antibody response to trivalent inactivated split influenza vaccine in subjects previously vaccinated or vaccinated for the first time, Vaccine, vol.14, issue.12, pp.1108-1110, 1996.
DOI : 10.1016/0264-410X(96)00061-8

H. Silvennoinen, V. Peltola, P. Lehtinen, R. Vainionpaa, and T. Heikkinen, Clinical Presentation of Influenza in Unselected Children Treated as Outpatients, The Pediatric Infectious Disease Journal, vol.28, issue.5, pp.372-375, 2009.
DOI : 10.1097/INF.0b013e318191eef7

F. Carrat, C. Pelat, D. Levy-bruhl, I. Bonmarin, and N. Lapidus, Planning for the next influenza H1N1 season: a modelling study, BMC Infectious Diseases, vol.6, issue.Suppl 1, p.301, 2010.
DOI : 10.1371/journal.pmed.1000207

URL : https://hal.archives-ouvertes.fr/inserm-00668438

G. Rimmelzwaan and J. Mcelhaney, Correlates of protection: Novel generations of influenza vaccines, Vaccine, vol.26, issue.4, pp.41-44, 2008.
DOI : 10.1016/j.vaccine.2008.07.043

Z. Xing and C. Cardona, Preexisting Immunity to Pandemic (H1N1) 2009, Emerging Infectious Diseases, vol.15, issue.11, pp.1847-1849, 2009.
DOI : 10.3201/eid1511.090685

D. Hobson, R. Curry, A. Beare, and A. Ward-gardner, SUMMARY, Journal of Hygiene, vol.90, issue.04, pp.767-777, 1972.
DOI : 10.1136/bmj.2.5404.271

H. Conseil-de-la-sante-publique, Advice regarding the updating of the influenza 2010?2011 vaccine strategy] Avis relatif a ` l'actualisation de la stratégie vaccinale contre la grippe 2010?2011, 2010.